NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

Q3 2026 DAYBUE net sales up 39%, full year guidance upgraded

Date and time
Announcement type
Financial Results

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV